Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-21

Clinical Trial Update: Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating gabapentin for postoperative pain after ureteroscopy with stent insertion was terminated; results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Northwestern University | Conditions: Anesthesia, Urethral Obstruction | Phase 4 | Status: TERMINATED | Results posted: 2022-07-21